Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FY18Z
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,284
Award facts
- Contract value 100% obligated
- $9,284.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, reflecting the vendor's competitive capabilities in unrestricted federal procurement. DMS Pharmaceutical Group operates as a critical supplier within the Department of Defense's pharmaceutical supply chain, specializing in the distribution of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, valued at $499,999,999 and awarded on November 13, 2025, extends through December 31, 2036, and establishes the vendor as one of multiple regional prime vendor contractors supporting the broader $30.3 billion PPV-G GEN V acquisition strategy. Through this contract vehicle, DMS Pharmaceutical Group is authorized to supply a comprehensive range of pharmaceutical products to support recurring medical supply needs of Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FY18Z?
SPE2DB26FY18Z was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FY18Z worth?
The government has obligated $9,284 on SPE2DB26FY18Z.
Is contract SPE2DB26FY18Z an order under another contract?
Yes. SPE2DB26FY18Z is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB26FY18Z competed?
The extent of competition for SPE2DB26FY18Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award